Back to Creative Planning Creative Planning

ACRSACRS

Showing 4 of 12 quarters

Position history for Creative PlanningCreative Planning's holdings in Aclaris Therapeutics, Inc.

Yes. Creative Planning holds 258,367 shares of ACRS (Aclaris Therapeutics), worth $1.4M, as of its Q3 2026 13F filing. It increased the position by 51,720 shares (+25.0%) from Q2 2026. Creative Planning has held ACRS since Q4 2025, across 4 quarterly 13F filings.

Current Value

$1.4M

Current Shares

258,367

Total Value Change

+$1.2M

Total Shares Change

+207,196

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
258,367
+25.0%
$1.4M0.0%$5.26
31
2026-Q2
Increased
206,647
+35.9%
$1.1M0.0%$5.29
33
2026-Q1
Increased
152,088
+197.2%
$570,3300.0%$3.75
39
2025-Q4
New
51,171
—
$154,0250.0%$3.01
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used